A detailed history of Van Eck Associates Corp transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Van Eck Associates Corp holds 987 shares of TMDX stock, worth $68,191. This represents 0.0% of its overall portfolio holdings.

Number of Shares
987
Previous 1,179 16.28%
Holding current value
$68,191
Previous $178,000 34.27%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$135.68 - $176.11 $26,050 - $33,813
-192 Reduced 16.28%
987 $117,000
Q2 2024

Jul 31, 2024

SELL
$72.62 - $150.62 $42,410 - $87,962
-584 Reduced 33.13%
1,179 $178,000
Q1 2024

Apr 30, 2024

BUY
$70.86 - $89.93 $12,400 - $15,737
175 Added 11.02%
1,763 $130,000
Q4 2023

Feb 05, 2024

SELL
$36.74 - $81.08 $19,802 - $43,702
-539 Reduced 25.34%
1,588 $125,000
Q3 2023

Nov 08, 2023

BUY
$53.47 - $96.07 $31,921 - $57,353
597 Added 39.02%
2,127 $116,000
Q2 2023

Aug 03, 2023

BUY
$66.23 - $88.73 $101,331 - $135,756
1,530 New
1,530 $128,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.2B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Van Eck Associates Corp Portfolio

Follow Van Eck Associates Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.